Bristol Myers Squibb Company (BMY) vs GSK PLC Sponsored ADR (GSK)
- Bristol Myers Squibb Company BMY 59.71 −1.42%
- GSK PLC Sponsored ADR GSK 49.55 +1.08%
Bristol Myers Squibb Company and GSK PLC Sponsored ADR are both Drug Manufacturers General companies. Bristol Myers Squibb Company is the larger, with a market value of $123.7B against $98.2B — 1.3× the size. Bristol Myers Squibb Company trades at the lower P/E: 13.2× against 15.4×. GSK PLC Sponsored ADR grew revenue faster over the last twelve months: 8.72% against 3.11%. Bristol Myers Squibb Company has the higher net margin (18.9% vs 14.6%) and the higher return on invested capital (13.7% vs 12.6%). Both pay a dividend; Bristol Myers Squibb Company yields more (4.22% vs 3.67%). Across the 23 metrics below, Bristol Myers Squibb Company leads on 14 and GSK PLC Sponsored ADR on 9.
Valuation
Profitability
| Metric | BMY | GSK | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 70.16% | 72.75% | 72.77% |
| Operating margin | 24.22% | 19.55% | 18.77% |
| Net margin | 18.87% | 14.58% | 8.27% |
| Free cash flow margin | 23.26% | 17.18% | 17.18% |
| Return on equity | 46.63% | 30.74% | 5.87% |
| Return on assets | 10.18% | 8.01% | 2.57% |
| Return on invested capital | 13.69% | 12.58% | 6.11% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack